- ongoing, recruitingTherapeutic exploratory (Phase II)
Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial.- The CARAMEL Study
This study, called CARAMEL, is looking at whether a cannabis-related medicine (CBD) can help people reduce their drinking when they have alcohol use disorder. It also checks if CBD can affect how alcohol impacts the brain and liver. It's a key step in understanding new ways to help.
France - active not recruitingPHASE4
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
This study looks at whether a medicine called semaglutide (Wegovy®), along with healthy eating and exercise, can help people who have gained weight from certain mental health medications. It aims to reduce weight gain linked to antipsychotic treatment.
United Kingdom